Abate As Industries Ltd Upgraded to Sell on Technical Improvement Despite Lingering Financial Challenges

Quality Assessment: Weak Fundamentals Persist

Abate As Industries Ltd’s quality rating remains subdued due to its ongoing operational losses and weak long-term fundamentals. The company reported an operating loss in the latest quarter, which has contributed to a negative return on equity (ROE). Specifically, the ROE stands at a mere 0.6%, signalling limited profitability relative to shareholder equity. This weak profitability is compounded by the company’s poor ability to service debt, with an average EBIT to interest coverage ratio of just 0.19, indicating significant financial strain.

While the company has declared positive results for the last two consecutive quarters, including a notable increase in net sales to ₹84.82 crores over the latest six months and a PAT of ₹7.13 crores, these gains have yet to translate into a robust fundamental turnaround. The PBDIT for the quarter reached ₹3.94 crores, marking a high point, but the overall financial trend remains fragile.

Valuation: Expensive Despite Weak Returns

Valuation metrics continue to weigh heavily on Abate As Industries Ltd’s rating. The stock trades at a price-to-book value of 1, which is considered very expensive given the company’s lacklustre financial performance. Over the past year, the stock’s return data is not available (NA), but profits have stagnated with zero growth, raising concerns about the sustainability of its current valuation. This disconnect between price and earnings performance has contributed to the company’s micro-cap status and the cautious stance adopted by analysts.

Financial Trend: Mixed Signals Amidst Positive Quarterly Results

Despite the weak long-term fundamentals, Abate As Industries Ltd has shown some encouraging signs in its recent financial trend. The company’s net sales growth of 8,481,999,900.00% over the last six months is an outlier figure that reflects a significant increase in revenue, albeit from a low base. The PAT and PBDIT improvements in the latest quarters suggest a potential inflection point, supported by rising promoter confidence. Promoters have increased their stake by 4.86% over the previous quarter, now holding 32.42% of the company, signalling strong insider belief in the company’s future prospects.

However, the company’s long-term financial strength remains weak, with operating losses and poor debt servicing capacity continuing to cast a shadow over its outlook.

Technical Analysis: Upgrade Driven by Improved Market Signals

The primary catalyst for the upgrade from Strong Sell to Sell is the improvement in technical indicators. The technical trend has shifted from bearish to mildly bearish, reflecting a less negative momentum in the stock price. Key technical metrics present a nuanced picture:

• MACD: Weekly readings remain bearish, but monthly MACD has improved to mildly bearish.
• RSI: Both weekly and monthly RSI show no clear signal, indicating a neutral momentum.
• Bollinger Bands: Weekly bands remain bearish, while monthly bands have softened to mildly bearish.
• Moving Averages: Daily moving averages continue to signal bearishness, suggesting short-term caution.
• KST (Know Sure Thing): Weekly KST is mildly bullish, indicating some positive momentum, though monthly KST remains mildly bearish.
• Dow Theory: No clear trend is identified on either weekly or monthly timeframes.
• On-Balance Volume (OBV): Weekly OBV shows no trend, but monthly OBV is bullish, suggesting accumulation over the longer term.

These mixed technical signals have led to a cautious upgrade, reflecting a potential stabilisation in the stock’s price action. The current price stands at ₹10.37, down 1.52% on the day, with a 52-week range between ₹10.00 and ₹26.20. The stock has underperformed the Sensex significantly over the short and medium term, with a one-month return of -11.22% versus Sensex’s -1.98%, and a year-to-date return of -40.74% compared to Sensex’s -10.80%. However, the stock’s long-term 10-year return of 764.17% far outpaces the Sensex’s 196.97%, highlighting its historical growth potential despite recent volatility.

Market Capitalisation and Industry Context

Abate As Industries Ltd is classified as a micro-cap stock within the hospital sector, which itself is a niche segment of the broader healthcare industry. The company’s micro-cap status reflects its relatively small market capitalisation and heightened risk profile. Investors should weigh the company’s recent technical improvements against its fundamental weaknesses and sector dynamics before making investment decisions.

Conclusion: A Cautious Upgrade Reflecting Technical Stabilisation

The upgrade of Abate As Industries Ltd’s investment rating from Strong Sell to Sell is primarily driven by an improvement in technical indicators, signalling a potential easing of downward momentum. However, the company’s fundamental challenges remain significant, including operating losses, weak debt servicing ability, and expensive valuation metrics relative to its earnings performance.

Promoter confidence has increased, with a 4.86% rise in stakeholding, which may provide some support for future growth. Yet, investors should remain cautious given the stock’s recent underperformance relative to the broader market and the hospital sector’s competitive landscape.

Overall, while the technical upgrade offers a glimmer of hope, Abate As Industries Ltd’s rating reflects a balanced view that recognises both the potential for recovery and the risks posed by its current financial and valuation profile.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →